prescription drugs
-
PublishedFebruary 19, 2022
Commentary: What we can learn about making cancer drugs from developing the COVID vaccines
Public-private partnerships, which bring together experts with diverse talents and robust resources, succeeded against the coronavirus. Let’s try them against cancer.
-
PublishedFebruary 14, 2022
Bill aims to lower the cost of the most expensive prescription drugs for Mainers
The bill would ensure that Mainers pay no more for prescription medications than their Canadian neighbors.
-
PublishedFebruary 10, 2022
Biden puts focus on prescription drug prices in fight against inflation
President Biden is trying to jump-start progress on his stalled domestic agenda by refocusing attention on one of his most popular proposals, limiting the cost of prescription drugs.
-
PublishedJanuary 22, 2022
Another View: Lifetime bans a fitting punishment for ‘Pharma Bro’ and his ilk
Martin Shkreli would jack up the price of lifesaving drugs all over again if he had the chance.
-
PublishedNovember 19, 2021
Commentary: Focus on hearing aids, not a questionable Alzheimer’s drug
Alzheimer’s groups will help far more people by promoting hearing aids and a healthy lifestyle than by touting Aduhelm.
-
PublishedNovember 10, 2021
Maine Voices: There is a state-level solution to high prescription drug costs
Other states have passed laws regulating pharmacy reimbursements. Why not Maine?
-
PublishedNovember 9, 2021
Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson
The Oklahoma Supreme Court weighed whether the company’s marketing and sale of opioids created a public nuisance.
-
PublishedNovember 2, 2021
Democrats reach deal on lowering drug prices; Biden upbeat on Manchin
Democrats are looking to cap out-of-pocket Medicare drug costs at $2,000 and reduce the price of insulin, as part of President Biden's $1.75 trillion domestic policy proposal.
-
PublishedJuly 29, 2021
Our View: Opioid settlement funds must address addiction crisis
Deals are being reached with the companies responsible for shipping habit-forming medications across the U.S., and the proceeds must be used wisely.
-
PublishedJuly 2, 2021
Commentary: The Alzheimer’s mistake by the FDA is already getting worse
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence.
- ← Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 8
- Next Page →